Criterium

Executive Summary

Criterium is a full-service clinical research organization (CRO) founded in 1993, specializing in oncology clinical trials and digital health solutions. The company differentiates itself through a unique consortium model that leverages collaborative networks of leading academic institutions, aiming to accelerate the development of new cancer therapies. Its proprietary technology platforms support comprehensive services from trial design to completion. Despite being a private company with limited public disclosures, Criterium's long-standing presence and niche focus position it as a specialized player in the CRO space, particularly in the growing oncology and digital health sectors. The company is headquartered in Saratoga Springs, New York, and operates in a market where demand for efficient, technology-enabled clinical trials is rising.

Upcoming Catalysts (preview)

• Q3 2026Major pharmaceutical partnership for oncology trial50% success
• Q2 2026Launch of new digital health platform for remote monitoring60% success
• Q4 2026Expansion into new therapeutic area via consortium model40% success